Streetbeat News

Stock Prices

JANX

Janux Therapeutics Inc (NASDAQ:JANX) announced positive interim Phase 1 clinical data for its prostate cancer candidate, PSMA-TRACTr JANX007. The drug has been well tolerated with no dose-limiting toxicities and showed clinical activity. Concurrently, Janux priced an underwritten offering of over 4 million shares and pre-funded warrants, expecting to raise approximately $60 million. William Blair notes that Janux shares are currently undervalued based on the potential of the company’s TRACTr platform.

Portfolio Pulse from Vandana Singh

July 17, 2023 | 6:36 pm

DIS

EXPE

IAC

NFLX

Barry Diller, chairman of IAC Inc and Expedia Group Inc, suggests that both executives and top-paid actors should take a 25% pay cut to narrow the pay gap in the movie industry. The Writers Guild of America and SAG-AFTRA are on strike, which could have devastating effects on the movie industry if not resolved by September 1. Wedbush analyst Alicia Reese believes the strikes could impact Netflix's Q3, while other studios with struggling streaming platforms could be hit harder. Disney CEO Bob Iger is concerned about the unrealistic expectations of the strikers.

Portfolio Pulse from Anthony Noto

July 17, 2023 | 6:33 pm

CHPT

TSLA

Oppenheimer analyst Colin Rusch reiterated an Outperform rating on ChargePoint Holdings Inc (CHPT) with a price target of $8.26. The analyst highlighted ChargePoint's key role in the EV charging landscape, its ability to service any OEM design, and its potential for positive operating leverage as channel revenues grow. The company is also well capitalized as it drives toward positive adjusted EBITDA in F2Y4.

Portfolio Pulse from Shivani Kumaresan

July 17, 2023 | 6:33 pm

NOW

A significant investor has taken a bearish stance on ServiceNow (NYSE:NOW), with 80% of recent trades indicating bearish expectations. The targeted price range for ServiceNow over the last 3 months is $490.0 to $700.0. The current price of NOW is up 2.19% at $593.08, with RSI indicators suggesting the stock may be approaching overbought. The next earnings are expected in 9 days.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 6:32 pm

ARKK

COIN

META

TSLA

ARK Invest, led by Cathie Wood, has reduced its stake in Twitter by 47% since it was taken private by Elon Musk. Despite Twitter's substantial debt burden and a significant decline in advertising revenue, Wood remains optimistic about its long-term prospects. ARK Invest continues to hold Tesla, Inc. and Coinbase Inc. as leading investments in its ARK Innovation ETF fund. The firm has also recently purchased a substantial number of shares in Meta Platforms.

Portfolio Pulse from Piero Cingari

July 17, 2023 | 6:31 pm

VTGN

Vistagen Inc has revealed new data from a preclinical study of its itruvone nasal spray, a potential treatment for major depressive disorder. The study showed that a single intranasal administration of itruvone was undetectable in the brain and most other tissues, supporting the proposed mechanism of action of the spray. Vistagen recently reported that itruvone is now staged for potential Phase 2B clinical development in the U.S. VTGN shares are up 1.69% at $1.80 on the last check Monday.

Portfolio Pulse from Vandana Singh

July 17, 2023 | 6:31 pm

JCI

Johnson Controls Intl (NYSE:JCI) has outperformed the market over the past 15 years by 2.33% on an annualized basis, producing an average annual return of 11.12%. If an investor had bought $100 of JCI stock 15 years ago, it would be worth $503.53 today.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 6:30 pm

TSM

Taiwan Semiconductor (NYSE:TSM) has outperformed the market over the past 20 years, producing an average annual return of 13.69%. If an investor had bought $1000 of TSM stock 20 years ago, it would be worth $12,732.42 today.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 6:30 pm

ESLT

FRSX

Foresight Autonomous Holdings Ltd (FRSX) has signed an exclusive commercialization agreement with Elbit Systems Land Ltd, a subsidiary of Elbit Systems Ltd (ESLT). The agreement is for the integration, marketing, and licensing of Foresight's image processing software solution. Foresight expects revenues of up to $4 million over a contractual period of five years, with minimum guaranteed revenues of $1 million. FRSX shares are trading higher by 19.6% at $3.17.

Portfolio Pulse from Shivani Kumaresan

July 17, 2023 | 6:28 pm

FACT

Shares of Freedom Acquisition I Corp. have resumed trading.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 6:24 pm